Last Tuesday of the Month (6:30-7:30 PM).
Kings Highway Library: 2115 Ocean Ave
Facilitator: Greg Romenski
The new effort aims to stop the Hepatitis C virus in its tracks by increasing access to medications that can cure Hepatitis C and expanding programs to connect New Yorkers in high-risk communities with wrap-around Hepatitis C prevention, screenings and treatment services.
The FDA has approved the drug Epclusa to treat adult patients with chronic Hep C both with and without cirrhosis.
The Centers for Medicare and Medicaid Services (CMS) made the final decision to cover screening for hepatitis B infection at no cost to individuals entitled to benefits under Medicare Part A or enrolled in Medicare Part B.
In recognition of Hepatitis Testing Day, May 19, The AIDS Institute has released a Hepatitis C (HCV) Testing Coverage Guide to assist health care providers with navigating each of the major healthcare payers’ coverage options for preventive services, specifically for HCV screen...
Great resources to obtain medication at little or no cost !
We have the tools to prevent the major causes of viral hepatitis and liver cancer – a hepatitis B vaccine and effective treatments that reduce disease progression, new diagnostics for HCV and treatments that increase cure rates over 90%, and even more medical advances in the re...
City Council demonstrated its commitment to hepatitis elimination by continuing support for the Viral Hepatitis Initiative, which has improved health care access for over 8,000 New Yorkers at risk for or living with hepatitis B or C, and trained over 800 clinical providers.